Adage Capital Partners GP »

Arcutis Biotherapeutics shares owned by Adage Capital Partners GP

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Adage Capital Partners GP from 13F filings

Historical chart of Adage Capital Partners GP investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by Adage Capital Partners GP consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by Adage Capital Partners GP

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.4M 100k 13.93
2024-06-30 $1.9M 200k 9.30

More positions owned by Adage Capital Partners GP

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Procter & Gamble Company (PG)
ConocoPhillips (COP)
Visa Com Cl A (V)

View all positions for Adage Capital Partners GP

Top funds holding Arcutis Biotherapeutics

Jennison Associates
Rubric Capital Management
Suvretta Capital Management
Frazier Life Sciences Management
BlackRock
Vanguard Group
Polar Capital Holdings
State Street Corporation
Gilder, Gagnon, Howe & Co
Morgan Stanley
UBS Group
Geode Capital Management
Henderson Group
Franklin Resources
Pivotal bioVenture Partners Investment Advisor

View all funds holding Arcutis Biotherapeutics